You are here

Pfizer/BioNTech seeks U.S. nod for updated COVID vaccine as booster in kids under 5

Primary tabs

Wed, 2023-03-01 17:10 — mike kraft

Pfizer/BioNTech seeks U.S. nod for updated COVID vaccine as booster in kids under 5 Pfizer Inc and its German partner BioNTech SE have applied for emergency use authorization of their Omicron-adapted COVID-19 vaccine in the United States as a booster dose for children aged six months through four years, the companies said on Wednesday. The Omicron-adapted vaccine is currently authorized by the U.S. health regulator as the third dose of the three-dose primary course of vaccination in the country for children in this age group. Reuters Reuters

Country / Region Tags:

General Topic Tags:

Disease Prevention

Problem, Solution, SitRep, or ?:

Situation Report

Groups this Group Post belongs to:

- Private group -

Log in or register to post comments

Page loaded in 0.409 seconds.